Study: Repeated Ketamine Infusions Reduce Severity of PTSD Symptoms | The Jewish Press - JewishPress.com | Hana Levi Julian | 23 Tevet 5781 – January 6, 2021

American Journal of Psychiatry, is the first randomized, controlled trial of repeated ketamine administration for chronic PTSD and suggests this may be a promising treatment for PTSD patients.
“Our findings provide insight into the treatment efficacy of repeated ketamine administration for PTSD, an important next step in our quest to develop novel pharmacologic interventions for this chronic and disabling disorder, as a large number of individuals are not sufficiently helped by currently available treatments,” said Adriana Feder, MD, Associate Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai and lead author of the study.
“The data suggests repeated IV ketamine is a promising treatment for people who suffer from PTSD and provides evidentiary support to warrant future studies to determine how we can maintain this rapid and robust response over time.”

Related Keywords

United States ,American ,Denniss Charney ,Rebecca Moninghoff Pixabay ,Adriana Feder ,Icahn School Of Medicine At Mount Sinai ,Drug Administration ,Photo Credit ,Rebecca Moninghoff ,New York City ,Icahn School ,American Journal ,Associate Professor ,Mount Sinai ,Joel Ehrenkranz Dean ,Academic Affairs ,Mount Sinai Health ,Clinician Administered ,Montgomery Asberg Depression Rating Scale ,ஒன்றுபட்டது மாநிலங்களில் ,அமெரிக்கன் ,இக்ஹ்ன் பள்ளி ஆஃப் மருந்து இல் ஏற்ற சினை ,புகைப்படம் கடன் ,புதியது யார்க் நகரம் ,இக்ஹ்ன் பள்ளி ,அமெரிக்கன் இதழ் ,இணை ப்ரொஃபெஸர் ,ஏற்ற சினை ,ஏற்ற சினை ஆரோக்கியம் ,